Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_assertion description "[Quantitative methylation specific polymerase chain reaction showed that IGFBP7 methylation was more frequently detected in prostate cancer (60% (31/52)) and high grade prostatic intraepithelial neoplasia (40% (6/15)) samples compared to histologically benign prostate adjacent to tumor (10%) and benign prostatic hyperplasia (0%) samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_assertion evidence source_evidence_literature NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_assertion SIO_000772 22906661 NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_assertion wasDerivedFrom befree-2016 NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_assertion wasGeneratedBy ECO_0000203 NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.
- befree-2016 importedOn "2016-02-19" NP1006621.RA4NkLtJIxcSFx8eV3j9HTgpqUNjX7s9vhiWbAgfnWHdI130_provenance.